Sign in
Combination therapy with triamcinolone acetonide and bevacizumab for the treatment of severe radiation maculopathy in patients with posterior uveal melanoma
Journal article   Open access  Peer reviewed

Combination therapy with triamcinolone acetonide and bevacizumab for the treatment of severe radiation maculopathy in patients with posterior uveal melanoma

Nisha V Shah, Samuel K Houston, Arnold Markoe and Timothy G Murray
Clinical ophthalmology (Auckland, N.Z.), Vol.7, pp.1877-1882
2013
PMCID: PMC3788818
PMID: 24092966

Abstract

bevacizumab triamcinolone acetonide Original Research uveal melanoma radiation maculopathy
url
https://doi.org/10.2147/OPTH.S47684View
Published (Version of record) Open

Metrics

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details